Influence of CYP3A5 Polymorphism in Donor and Recipient on Tacrolimus Pharmacokinetics and Clinical Outcome after Renal Transplantation

被引：0
|
作者：
Cauffiez, Christelle [1 ]
Glowacki, Francois [2 ]
Lionet, Arnaud [2 ]
Provot, Francois [2 ]
Hazzan, Marc [2 ]
Noel, Christian [2 ]
Allorge, Delphine [1 ]
Broly, Franck [1 ]
机构：
[1] Univ Lille 2, Fac Med Pole Rech, EA2679, F-59800 Lille, France
[2] CHRU Lille, Hop Calmette, Lille, France
来源：
THERAPEUTIC DRUG MONITORING | 2009年 / 31卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号：
1001 ;
摘要：
203
引用
收藏
页码：661 / 661
页数：1
相关论文
共 50 条
  • [41] CYP3A5 Polymorphism in Renal Transplantation: A Key to Personalized Immunosuppression
    Pasari, Amit S.
    Balwani, Manish R.
    Gurjar, Prasad
    Bawankule, Charulata
    Bhawane, Amol
    Tolani, Priyanka
    Kashiv, Pranjal
    Dubey, Shubham
    Katekhaye, Vijay M.
    TRANSPLANTATION PROCEEDINGS, 2023, 55 (05) : 1305 - 1309
  • [42] Influence of donor CYP3A5 gene polymorphism on tacrolimus dose requirement in pediatric liver transplant recipients
    Ayme, E.
    Debray, D.
    Durand, P.
    Fabre, M.
    Furlan, V.
    Bouligand, J.
    Kolaci, M.
    Verstuyft, C.
    Becquemont, L.
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2011, 25 : 75 - 75
  • [43] CYP3A5 Polymorphism in Renal Transplantation: A Key To Personalized Medicine
    Gurjar, Prasad
    Pasari, Amit
    Bhawane, Amol
    Tolani, Priyanka
    Kolte, Sanjay
    Katekhaye, Vijay
    Balwani, Manish
    TRANSPLANTATION, 2022, 106 (09) : S160 - S160
  • [44] Frequency of CYP3A5 Genetic Polymorphisms and Tacrolimus Pharmacokinetics in Pediatric Liver Transplantation
    Buendia, Jefferson Antonio
    Halac, Esteban
    Bosaleh, Andrea
    Garcia de Davila, Maria T.
    Imvertasa, Oscar
    Bramuglia, Guillermo
    PHARMACEUTICS, 2020, 12 (09) : 1 - 7
  • [45] INFLUENCE OF DONOR AND RECIPIENT CYP3A5 AND ABCB1 GENETIC POLYMORPHISMS ON TACROLIMUS DOSAGE AND TROUGH LEVEL
    Iacob, Speranta
    Maschmeier, Miriam
    Huesing, Anna
    Kabar, Iyad
    Schmidt, Hartmut
    Cicinnati, Vito
    Beckebaum, Susanne
    TRANSPLANT INTERNATIONAL, 2017, 30 : 193 - 193
  • [46] Combinational Effect of Intestinal and Hepatic CYP3A5 Genotypes on Tacrolimus Pharmacokinetics in Recipients of Living Donor Liver Transplantation
    Ji, Eunhee
    Choi, Leena
    Suh, Kyung-Suk
    Cho, Joo-Youn
    Han, Nayoung
    Oh, Jung Mi
    TRANSPLANTATION, 2012, 94 (08) : 866 - 872
  • [47] Effects of CYP3A5, ABCB1 and POR*28 polymorphisms on pharmacokinetics of tacrolimus in the early period after renal transplantation
    Ling, Jing
    Dong, Lu-Lu
    Yang, Xu-Ping
    Qian, Qing
    Jiang, Yan
    Zou, Su-Lan
    Hu, Nan
    XENOBIOTICA, 2020, 50 (12) : 1501 - 1509
  • [48] Effect of CYP3A5 polymorphism on the pharmacokinetics of tacrolimus and acute rejection in renal transplant recipients: experience at a single centre
    Cheng, Y.
    Li, H.
    Meng, Y.
    Liu, H.
    Yang, L.
    Xu, T.
    Yu, J.
    Zhao, N.
    Liu, Y.
    INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2015, 69 : 16 - 22
  • [49] CYP3A5 and ABCB1 genotype influence tacrolimus and sirolimus pharmacokinetics in renal transplant recipients
    Li, Yi
    Yan, Lin
    Shi, Yunying
    Bai, Yangjuan
    Tang, Jiangtao
    Wang, Lanlan
    SPRINGERPLUS, 2015, 4
  • [50] Effect of CYP3A5*1/*3 polymorphism in Tacrolimus dose requirements in kidney transplantation
    Montes Ares, Olga
    Guerra Rodriguez, Rita
    Torio Ruiz, Alberto
    Fernandez Tagarro, Ernesto
    Gonzalez Henriquez, Maria Isabel
    Perez Valentin, Miguel Angel
    Trejo Benitez, Maria Ceferina
    Dolores Checa de Andres, Maria
    TISSUE ANTIGENS, 2010, 75 (05): : 605 - 605
12345